NCT03409458 — Non-Small Cell Lung Cancer (NSCLC) trial site landscape

Public-registry site landscape for NCT03409458, a Non-Small Cell Lung Cancer (NSCLC) study sponsored by Promontory Therapeutics Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03409458 (registry record)
Sponsor	Promontory Therapeutics Inc.
Condition(s)	Non-Small Cell Lung Cancer (NSCLC)
Phase	PHASE1 / PHASE2
Listed sites	6
Site countries	United States, Switzerland

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03409458 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.